Publications
- Allogeneic Stem Cell Transplantation in Patients With FLT3-ITD Mutated AML: Transplantation in CR1 Is the Decisive Factor for Good Outcome2019 | Faculty of Medicine in Pilsen
- Possible discontinuation of treatment by tyrosine kinase inhibitors in patients with chronic myeloid leukemia and concept of treatment-free remission2017 | Publication without faculty affiliation
- Pre-transplant Quantitative Determination of NPM1 Mutation Significantly Predicts Outcome of AIlogeneic Hematopoietic Stem Cell Transplantation in Patients with Normal Karyotype AML in Complete Remission2016 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Chronic myeloid leukaemia - standardization of BCR-ABL1 transcript level monitoring in the Czech Republic2016 | Publication without faculty affiliation
- Current survival measures reliably reflect modern sequential treatment in CML: Correlation with prognostic stratifications2013 | Faculty of Medicine in Pilsen, Third Faculty of Medicine
- Evaluation of 5-year imatinib treatment of 458 patients with CP-CML in routine clinical practice and prognostic impact of different BCR-ABL cutoff levels2013 | Faculty of Medicine in Pilsen, Central Library of Charles University
- De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors2024 | Faculty of Medicine in Pilsen, Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective study2024 | Publication without faculty affiliation
- Determinants of refined GvHD-free, relapse-free survival after reduced-intensity allogeneic hematopoietic cell transplantation in older patients with myeloid malignancies2023 | Faculty of Medicine in Pilsen
- Allogeneic stem cell transplantation in patients with multiple myeloma-single center experience2023 | Publication without faculty affiliation
Loading network view...